BREAKTHROUGH EFFECTIVE TREATMENT FOR DEPRESSION PATIENTS
BREAKTHROUGH EFFECTIVE TREATMENT FOR DEPRESSION PATIENTS
Traditional treatments for Major Depressive Disorder, primarily antidepressants, have often failed to deliver satisfactory results for many patients. Brainsway introduces a breakthrough technology offering a new approach to treating depression through deep non-invasive brain stimulation.
Technology Overview
Brainsway's patented technology utilizes directed electromagnetic fields to rebalance abnormal brain structures. This method is based on patents from the U.S. National Institutes of Health and Brainsway itself. The treatment has been validated by over 60 clinical trials worldwide.
Advantages of Brainsway's Solution
Brainsway's Deep Transcranial Magnetic Stimulation (Deep TMS) offers several advantages over traditional treatments like antidepressants and Electroconvulsive Therapy (ECT). It is non-invasive, does not require anesthesia, and avoids systemic side effects. The treatment involves short daily sessions over 4-5 weeks, with no hospitalization needed.
Clinical Efficacy and Safety
The FDA and CE have approved Brainsway Deep TMS for patients with mild to severe depression who have not responded to antidepressants. A significant study demonstrated a profound decline in depression scores and high remission and response rates. The treatment is safe and well-tolerated.
Conclusion
Brainsway's Deep TMS technology provides an effective, safe, and convenient treatment option for depression patients, offering hope for those who have not found relief with traditional methods.
Catalog excerpts
BREAKTHROUGH EFFECTIVE TREATMENT FOR DEPRESSION PATIENTS H ave Antidepressants Failed to Achieve Results for Your Patients? Major Depressive Disorder has traditionally been treated with anti-depressants. However, research demonstrates that anti-depressants have failed to achieve satisfactory results for many patients 1 . The patented breakthrough technology of Brainsway TM unfolds a new dawn in Depression treatment. The company offers a clinically-proven solution for various categories of Depression patients, ranging from mild to severe Depression cases, who failed to achieve sufficient outcomes from existing treatments in the current episode. The treatment performs deep non-invasive brain stimulation using directed electromagnetic fields, thus rebalancing abnormal brain structures. Brainsway's technology is based on patents filed by the U.S. National Institutes of Health (NIH) and the company. The treatment has been enthusiastically embraced by the international academic community, with over 60 clinical trials in leading institutions worldwide, and a wide variety of psychiatric and neurological indications.
Open the catalog to page 1
Clinically Proven, Certified and Safe B rainsway's solution stands matchless in its advantages, as traditional Depression treatments have been shown to be insufficient in terms of efficacy and also entail significant side effects 1 . Antidepressants, on top of their unsatisfactory response rates, entail systemic side effects leading many patients to neglect their medication regime. Other alternatives, such as Electroconvulsive Therapy (ECT), require anesthesia and involve significant risks and side effects, while Surface TMS (Transcranial Magnetic Stimulation) is more limited in its ability...
Open the catalog to page 2
